Positioning Immune Checkpoint Inhibitor Treatment for TNBC

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

CECOG Academy

www.cecog.org

Pancreas Cancer Academy 2022
Breast Cancer Webinar
NSCLC 2022 Webinar
CECOG Immuno-Oncology Symposium
Pancreatic Cancer
Colon Cancer
Post ESMO Webinar
Post SABCS Webinar
Videos
Events

Playback speed

10 seconds

Positioning Immune Checkpoint Inhibitor Treatment for TNBC

By CECOG Academy FEATURING Rupert Bartsch

116 views

December 7, 2021

Comments 0

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Unmet Needs and Resistance Mechanisms in Patients With HR+, HER2- MB…

Feat. W. Mchayleh

CECOG Immuno-Oncology Symposium

Combining Immune Checkpoint Inhibitors With Tyrosine Kinase Inhibito…

CECOG Academy

T. Füreder

192 views

Updates on Cabozantinib in RCC, HCC, and Thyroid Cancers

CECOG Academy

B. Mrinakova

157 views

Efficacy of FDA-Approved Lenvatinib in Solid Cancers

CECOG Academy

A. Perdyan

44 views

From Bench to Bedside - CLL: Steps to Chemo-Free Therapy

CECOG Academy

U. Jaeger

150 views

SARS-CoV-2 Pandemic: Vaccination Against Coronavirus in Patients wit…

CECOG Academy

U. Wiedermann-Schmidt

32 views

Advances in IO Maintenance Treatment of Ovarian Cancer

CECOG Academy

C. Grimm

380 views

Adjuvant Treatment of Colon Cancer: Duration of Treatment and Patien…

CECOG Academy

G. Prager

223 views

Entrectinib in Advanced NSCLC and Other Solid Tumors: Updates and Ne…

CECOG Academy

A. Bandura

172 views

Advances in IO Neoadjuvant Treatment With Immune Checkpoint Inhibito…

CECOG Academy

C. Zielinski

38 views

Targeting KRAS Mutations in NSCLC

CECOG Academy

M. Filipits

85 views

Optimizing Immunotherapy for NSCLC in Daily Practice

CECOG Academy

T. Cufer

94 views